HCP 07
Medical Oncologist · Spain · Consultant
Illustrative synthetic data for prototype demonstration — not real clinical findings.
Discussion summary
Supportive with conditions; emphasises multidisciplinary input and monitoring burden.
Key themes
Pre / post perception
Overall perception shiftPre-congress vs post-congress
3 improved · 1 declined
Perception of clinical efficacy
Confidence in the evidence
Safety / tolerability perception
Likelihood to prescribe
Familiarity with treatment
Competitive perception
Illustrative synthetic measures. Movement is shown as an observed pre/post shift, not a causal effect of the congress.
KBQs discussed
Position against each predefined questionClinical significance of the primary endpoint
What is the expert consensus regarding the clinical significance of the study’s primary endpoint results?
“This is a setting where we badly need options, and this endpoint really moves the needle for me.”
Safety, tolerability and willingness to prescribe
How do HCP perceptions of the trial’s safety and tolerability profile impact their willingness to adopt and prescribe the treatment?
“How the patient feels week to week matters as much as the efficacy for me.”
Use in node-positive populations
What is the clinical consensus among HCPs regarding the use of CDK4/6 inhibitors in node-positive patient populations?
“In node-positive patients with higher recurrence risk, the case for treating is strong.”
Sequencing after adjuvant recurrence
How do clinicians approach treatment sequencing following recurrence on an adjuvant CDK4/6 inhibitor?
“I take it case by case rather than applying one rule to everyone.”
Compelling nature of the primary endpoint
How compelling are the primary endpoint findings in driving prospective prescribers to select this treatment over existing options?
“I would want to see the subgroup detail before it changes my first choice.”
Perception of safety and tolerability
How do experts perceive the safety and tolerability profile demonstrated in the trial?
“The profile is predictable and consistent with the class — nothing here surprises me.”